CLASS II ONGOING Device recall · Reported 25 Oct 2023 · FDA Enforcement Report

SenSight Connector Plug recalled by Medtronic Neuromodulation

Medtronic Neuromodulation is recalling SenSight Connector Plug, distributed nationwide in the US. The recall was initiated on 20 Jan 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesGTIN 00763000426576, Lot Number 082U30721
Quantity recalled65 devices

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0121-2024
FDA event ID
93083
Recalling firm
Medtronic Neuromodulation, Minneapolis, MN
Classification
Class II
Status
Ongoing
Recall initiated
20 Jan 2023
FDA classified
18 Oct 2023
Reported
25 Oct 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

20 Jan 2023Recall initiated by company
18 Oct 2023Classified by FDA+271 days
25 Oct 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Medtronic is requesting return of a small number of units of the SenSight Connector Plug, Model B31061, due to a discrepancy in the Use By Date (UBD) printed on the label.

Product as listed by the FDA

SenSight Connector Plug, Model Number B31061.

Where it was distributed

US Nationwide Distribution

Nationwide

Questions about this recall

Why was it recalled?

Medtronic is requesting return of a small number of units of the SenSight Connector Plug, Model B31061, due to a discrepancy in the Use By Date (UBD) printed on the label.

Which lots are affected?

GTIN 00763000426576, Lot Number 082U30721

Where was it sold?

US Nationwide Distribution

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Medtronic Neuromodulation

All 87

Other Other Medical Devices recalls

All 13,968